It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Dr. Shreeram Aradhye, Board Member of the Novartis Venture Fund

Dr. Shreeram Aradhye


Shreeram Aradhye MD is the President, Development and Chief Medical Officer for Novartis, and a member of the Executive Committee of Novartis. In this capacity, he is responsible for advancing the Novartis pipeline of investigational medicines to bring transformative new treatment options to patients with serious diseases. Dr. Aradhye took on his current role in May 2022, rejoining the company after spending several years at US biotechnology companies, including leading the development of multiple clinical stage RNAi assets at Dicerna Pharmaceuticals. He first joined Novartis in 1999 and, over the course of 20 years, held a succession of leadership roles in the US, Switzerland, Germany and India, including Global Head of Medical Affairs for the Pharmaceuticals Business Unit and Development Head for the Neuroscience Franchise. Before joining the life sciences industry, Dr. Aradhye was an attending physician and assistant professor of medicine and a transplant nephrologist at the University of Pennsylvania. He completed his medical training at the All India Institute of Medical Sciences in 1989, after which he received additional specialty training in internal medicine and nephrology in the US.